Soga Yoshimitsu, Tomoi Yusuke, Hiramori Seiichi, Murata Naotaka, Kobayashi Yohei, Ichihashi Kei, Aodo Kenji
1 Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
2 Department of Cardiology, Tokyo Medical University Hospital, Tokyo, Japan.
J Endovasc Ther. 2017 Aug;24(4):488-495. doi: 10.1177/1526602817707306. Epub 2017 May 3.
To report the safety and efficacy of a new technique to prevent distal embolism during treatment of iliofemoral occlusions: reverse flow aspiration with proximal sheath blockage (ReFLAP).
Between October 2013 and December 2014, 90 patients (mean age 74 years; 66 men) were prospectively enrolled in a study to evaluate the ReFLAP technique during treatment of 110 occlusions in the iliac artery (72, 65%) or superficial femoral artery (SFA; 38, 35%). The mean occlusion lengths of iliac and SFA lesions were 79 and 179 mm, respectively. The concept of ReFLAP is to aspirate debris after balloon dilation using reverse flow through collaterals without antegrade flow. The main endpoints were the incidence of distal embolization, amputation, complications, and the ReFLAP capture rate, which was visually estimated during aspiration using 4 prespecified grades (0, none; 1, foamy debris; 2, small particles; 3, massive particles).
ReFLAP was successful in 105 (95.4%) of the 110 lesions attempted; the 5 failures were due to severe vessel tortuosity or calcification. The incidences of distal embolization and amputation were both 0. Minor complications unrelated to ReFLAP were observed in 8 patients. The ReFLAP procedure aspirated debris in 57 (54%) of the 105 lesions. Aspirated material, including marked clots (grades 2 and 3), was confirmed in 40 (38%) of the lesions. The distribution of aspiration grades was significantly different between iliac and SFA lesions (p=0.02).
Our results suggest that the ReFLAP endovascular technique to prevent distal embolization during iliofemoral occlusive disease treatment is simple, safe, and effective.
报告一种在治疗髂股动脉闭塞症时预防远端栓塞的新技术的安全性和有效性:近端鞘管封堵逆流抽吸术(ReFLAP)。
2013年10月至2014年12月期间,90例患者(平均年龄74岁;66例男性)被前瞻性纳入一项研究,以评估在治疗110处髂动脉闭塞(72处,65%)或股浅动脉(SFA;38处,35%)时的ReFLAP技术。髂动脉和SFA病变的平均闭塞长度分别为79和179毫米。ReFLAP的概念是在球囊扩张后利用侧支循环的逆流抽吸碎片,而无顺行血流。主要终点为远端栓塞、截肢、并发症的发生率以及ReFLAP捕获率,后者在抽吸过程中使用预先设定的4个等级进行视觉评估(0级,无;1级,泡沫状碎片;2级,小颗粒;3级,大量颗粒)。
在尝试的110处病变中,105处(95.4%)成功实施了ReFLAP;5例失败是由于严重的血管迂曲或钙化。远端栓塞和截肢的发生率均为0。8例患者出现了与ReFLAP无关的轻微并发症。在105处病变中的57处(54%),ReFLAP操作抽吸到了碎片。在40处(38%)病变中确认抽吸到了包括明显血栓(2级和3级)在内的物质。髂动脉和SFA病变的抽吸等级分布存在显著差异(p = 0.02)。
我们的结果表明,在髂股动脉闭塞性疾病治疗中预防远端栓塞的ReFLAP血管内技术简单、安全且有效。